Travera gains commercial leader through MDisrupt network
Travera is an early-stage startup that helps oncologists speed cancer treatment decisions with their Rapid Therapy Guidance (RTG) Test. Using technology developed by MIT, the test is able to evaluate a broad range of FDA-approved therapies against a patient’s cancer to determine the optimal therapy – and provide results within two days of sample collection. The test offers truly individualized care, derived from a patient’s unique tumor cells.
Travera was seeking assistance with its go-to-market strategy and was contracting with MDisrupt to develop an Advisory Board to provide guidance on going to market in the oncology space. Throughout this process, MDisrupt identified the need for a commercial leader who could transform a promising startup into the leading cancer therapy guidance company in the marketplace.
Hiring can be a long and involved process, particularly candidate sourcing. MDisrupt identified the need for a commercial leader who could transform a promising startup into the leading cancer therapy guidance company in the marketplace.
Hiring can be a long and involved process, particularly candidate sourcing. With the healthcare industry’s deepest network of experts, MDisrupt’s Experts on Demand includes experts across disciplines with deep experience in healthcare. MDisrupt identified a candidate with 15+ years experience developing strategy, building commercial frameworks and selling to practicing academic and community oncologists – Travera’s target market.
Travera was able to move from first interview to accepted offer for their new Vice President of Business Development in just over 2 months – all without having to spend the traditional time and resources needed to identify, vet, and hire a commercial leader. They also avoided the potential pitfall of attempting to go to market without the right person in this critical role.